Incyte (INCY) Gross Profit Growth (1y) (2013 - 2026)
Powered by 
Analysis
Incyte (INCY) Gross Profit Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 126.09% |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 33.01% |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 57.16% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 351.57% |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | 38.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.03% |
| Mar 31, 2026 | 19.23% |
| Dec 31, 2025 | 27.10% |
| Sep 30, 2025 | 20.45% |
| Jun 30, 2025 | 17.54% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 15.54% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | 9.12% |
| Mar 31, 2024 | 9.06% |
| Dec 31, 2023 | 8.77% |
| Sep 30, 2023 | 11.74% |
| Jun 30, 2023 | 2.97% |
| Mar 31, 2023 | 8.87% |
| Dec 31, 2022 | 5.93% |
| Sep 30, 2022 | -0.57% |
| Jun 30, 2022 | 28.92% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | 31.86% |